Trisol – Percoutaneous Tricuspid Valve Replacement

• Category: Medical Devices
• Investment Status: Incubator
• Medical Field: Cardio-Vascular
• Patent Status: National
• Development Status: POC
• Medical Center: Beilinson

• Inventors: Dr. Mordehay Vaturi
  

TriSol Medical – develops a prosthetic percutaneous Tricuspid valve replacement. The Trisol valve is constructed of nitinol frame with specially designed leaflets. Its unique design provides a comprehensive solution to the unique anatomical and functional challenges which arise when treating Tricuspid Regurgitation by a replacement valve.

There are 1.6 million patients suffering from moderate to severe TR in the US. The price of prosthetic valves, which are currently commercial, is around $20K. As such, the total addressable market for Tricuspid replacement valve in the US alone amounts to tens of billions of dollars.

http://www.alon-medtech.com/companies-profile/